# SODIUM BISULFITE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid8034902
Categories: beauty, cleaning, food, industrial, pharma
Functions: Antioxidant, Biocide, Dye, Filler, Flavouring and nutrient, Hair waving or straightening, Preservative, Processing aids not otherwise specified, Reducing agent, Stabilizing agent, Surface modifier, Thickening agent
Identifier: DTXSID8034902

> SODIUM BISULFITE is used as antioxidant / biocide. EPA CPDat observed this chemical in 1071 composition records across product categories including Other indirect contact consumer goods, Laboratory supplies, Specialty occupational products. Assessed from 38 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 1071 composition records across product categories including Other indirect contact consumer goods, Laboratory supplies, Specialty occupational products.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 1071 composition records across product categories including Other indirect contact consumer goods, Laboratory supplies, Specialty occupational products. EPA CPDat classifies this chemical for functional uses including Stabilizing agent, Preservative, Antioxidant.
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.08 %w/v
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: NA
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: 0.32 %w/v
- US: inactive ingredient database — Route: INTRACARDIAC; Dosage form: INJECTION; Potency: 0.1 %w/v
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION; Potency: 0.32 %w/v
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 96 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 51.8 mg
- US: inactive ingredient database — Route: INTRAPERITONEAL; Dosage form: INJECTION; Potency: 0.66 %w/v
- US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION; Potency: 0.32 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 96 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 51.8 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.05 %w/v
- US: inactive ingredient database — Route: IONTOPHORESIS; Dosage form: SOLUTION; Potency: 0.06 %w/v
- US: inactive ingredient database — Route: IRRIGATION; Dosage form: INJECTION; Potency: 0.66 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: DROPS; Potency: 0.06 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.1 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 0.1 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.06 %w/w
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: 0.36 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Potency: 0.5 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Potency: 1 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 5 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 9 mg
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: INHALANT; Potency: NA
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: LIQUID; Potency: 0.3 %w/w
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Potency: 0.3 %w/w
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION; Potency: 0.1 %w/v
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 0.22 %w/v
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 0.5 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Potency: 0.3 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: POWDER, FOR SOLUTION; Potency: 0.1 %w/v
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: 0.06 %w/v
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._